Sentence examples for molecular technologies for from inspiring English sources

The goal of our laboratory is to develop, scale up, and broadly disseminate molecular technologies for mapping cells and functional circuits.

Here we trace the developments of sequence-based molecular technologies for investigating the diversity and functionality of microbiota in traditional or indigenous fermented foods and beverages.

Alice Ting, PhD, professor of genetics and of biology: She develops, scales up and broadly disseminates molecular technologies for mapping cells and functional circuits, as illustrated by her biotin-based method for protein mapping in living cells.

Despite a better knowledge of pathophysiology, and a wider use of new molecular technologies for the diagnosis, the etiological diagnosis of acute encephalitis is not assessed in most cases.

Of particular interest is applying these advances in molecular technologies for the development of in vitro diagnostic products that guide the safe and effective use of a corresponding therapeutic agent.

Molecular technologies for rapid detection of microorganisms in patients with sepsis have only recently become available.

The identified candidate DNA markers for the blind identification of animal adulteration in vegetarian food may be highly desirable in the vegetarian food market, and these markers may facilitate the study of molecular technology for food authentication.

However, most cases of M. fortuitum pneumonia were reported before the use of molecular technology for species identification.

One challenge of molecular technology for PGS is that the amplification of DNA from a single cell can result in errors.

OSNA is a novel molecular technology for CK19 mRNA-based identification of lymph node metastases in breast cancer and colorectal carcinomas (Tsujimoto et al, 2007; Croner et al, 2010; Yamamoto et al, 2011, 2013; Guller et al, 2012).

As the era of molecular technology for subtyping disease and identifying molecular targets takes huge leaps forward it is tempting to begin to ignore the more traditional morphological classification of disease and consider molecular subtyping (for example, luminal, basal, HER2 subtypes) and testing (for example, OncotypeDX) for classification and management.